Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KATHERINE KWON

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1891907770
CMS profile
531226
Location
SAINT JOSEPH, MI

General Payments · PY2018–2024

$79,660.32

  • Reported across 67 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$77,169.88

56 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $71,531.51 47
CALLIDITAS THERAPEUTICS US INC. $3,055.21 4
AKEBIA THERAPEUTICS INC $2,420.00 2
Amgen Inc. $131.37 1
Novo Nordisk AS $31.79 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $47.96 3
PY2019 $32.25 2
PY2020 $43.11 1
PY2022 $19.69 1
PY2023 $2,347.43 4
PY2024 $77,169.88 56

Payment records · PY2024 (56)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AKEBIA THERAPEUTICS INC $2,295.00 07/27/2024 Consulting Fee Undisputed 01/23/2026 1145832039 CMS
AKEBIA THERAPEUTICS INC $125.00 10/23/2024 Food and Beverage Undisputed 01/23/2026 1145832085 CMS
Amgen Inc. $131.37 04/17/2024 Food and Beverage Undisputed 01/23/2026 1111626297 CMS
AstraZeneca Pharmaceuticals LP $2,209.69 01/24/2024 Travel and Lodging Undisputed 01/23/2026 1104249013 CMS
AstraZeneca Pharmaceuticals LP $521.32 01/24/2024 Travel and Lodging Undisputed 01/23/2026 1105497141 CMS
AstraZeneca Pharmaceuticals LP $6,370.00 02/06/2024 Consulting Fee Undisputed 01/23/2026 1104220089 CMS
AstraZeneca Pharmaceuticals LP $480.44 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1105475947 CMS
AstraZeneca Pharmaceuticals LP $1,093.77 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1105783348 CMS
AstraZeneca Pharmaceuticals LP $283.58 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1105892088 CMS
AstraZeneca Pharmaceuticals LP $5,075.00 03/15/2024 Grant Undisputed 01/23/2026 1105616713 CMS
AstraZeneca Pharmaceuticals LP $1,600.00 04/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105471229 CMS
AstraZeneca Pharmaceuticals LP $3,200.00 04/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105658850 CMS
AstraZeneca Pharmaceuticals LP $30.02 04/11/2024 Food and Beverage Undisputed 01/23/2026 1105478211 CMS
AstraZeneca Pharmaceuticals LP $5,880.00 04/25/2024 Consulting Fee Undisputed 01/23/2026 1105752349 CMS
AstraZeneca Pharmaceuticals LP $100.00 04/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105704034 CMS
AstraZeneca Pharmaceuticals LP $66.82 06/20/2024 Food and Beverage Undisputed 01/23/2026 1105463371 CMS
AstraZeneca Pharmaceuticals LP $1,950.00 06/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105462883 CMS
AstraZeneca Pharmaceuticals LP $3,900.00 06/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104233107 CMS
AstraZeneca Pharmaceuticals LP $15.48 07/30/2024 Travel and Lodging Undisputed 01/23/2026 1104470378 CMS
AstraZeneca Pharmaceuticals LP $522.59 07/30/2024 Travel and Lodging Undisputed 01/23/2026 1105343867 CMS
AstraZeneca Pharmaceuticals LP $78.67 07/30/2024 Food and Beverage Undisputed 01/23/2026 1105703606 CMS
AstraZeneca Pharmaceuticals LP $656.18 07/30/2024 Travel and Lodging Undisputed 01/23/2026 1105868511 CMS
AstraZeneca Pharmaceuticals LP $125.00 07/31/2024 Food and Beverage Undisputed 01/23/2026 1104229761 CMS
AstraZeneca Pharmaceuticals LP $15.48 07/31/2024 Travel and Lodging Undisputed 01/23/2026 1105261280 CMS
AstraZeneca Pharmaceuticals LP $1,950.00 08/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104274563 CMS
AstraZeneca Pharmaceuticals LP $3,900.00 08/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104562832 CMS
AstraZeneca Pharmaceuticals LP $3,450.00 08/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105834991 CMS
AstraZeneca Pharmaceuticals LP $119.70 08/06/2024 Food and Beverage Undisputed 01/23/2026 1104255035 CMS
AstraZeneca Pharmaceuticals LP $465.27 08/06/2024 Travel and Lodging Undisputed 01/23/2026 1104564980 CMS
AstraZeneca Pharmaceuticals LP $63.56 08/06/2024 Travel and Lodging Undisputed 01/23/2026 1105376371 CMS
AstraZeneca Pharmaceuticals LP $151.79 08/06/2024 Travel and Lodging Undisputed 01/23/2026 1105378865 CMS
AstraZeneca Pharmaceuticals LP $13.03 08/06/2024 Food and Beverage Undisputed 01/23/2026 1105572565 CMS
AstraZeneca Pharmaceuticals LP $1,950.00 08/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105241518 CMS
AstraZeneca Pharmaceuticals LP $3,450.00 08/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105686383 CMS
AstraZeneca Pharmaceuticals LP $64.02 09/17/2024 Food and Beverage Undisputed 01/23/2026 1104394333 CMS
AstraZeneca Pharmaceuticals LP $107.20 09/17/2024 Travel and Lodging Undisputed 01/23/2026 1104703381 CMS
AstraZeneca Pharmaceuticals LP $3,900.00 09/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105648246 CMS
AstraZeneca Pharmaceuticals LP $1,160.01 10/09/2024 Travel and Lodging Undisputed 01/23/2026 1104366583 CMS
AstraZeneca Pharmaceuticals LP $76.56 10/09/2024 Travel and Lodging Undisputed 01/23/2026 1104638095 CMS
AstraZeneca Pharmaceuticals LP $1,392.86 10/09/2024 Travel and Lodging Undisputed 01/23/2026 1105291257 CMS
AstraZeneca Pharmaceuticals LP $63.00 10/09/2024 Food and Beverage Undisputed 01/23/2026 1105367822 CMS
AstraZeneca Pharmaceuticals LP $71.68 10/09/2024 Food and Beverage Undisputed 01/23/2026 1105578676 CMS
AstraZeneca Pharmaceuticals LP $66.56 10/09/2024 Travel and Lodging Undisputed 01/23/2026 1105643942 CMS
AstraZeneca Pharmaceuticals LP $14.80 10/10/2024 Food and Beverage Undisputed 01/23/2026 1105485171 CMS
AstraZeneca Pharmaceuticals LP $800.00 10/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105516261 CMS
AstraZeneca Pharmaceuticals LP $3,200.00 10/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105567608 CMS
AstraZeneca Pharmaceuticals LP $7,350.00 10/17/2024 Consulting Fee Undisputed 01/23/2026 1105486075 CMS
AstraZeneca Pharmaceuticals LP $127.43 10/24/2024 Food and Beverage Undisputed 01/23/2026 1105697976 CMS
AstraZeneca Pharmaceuticals LP $1,000.00 11/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105560080 CMS
AstraZeneca Pharmaceuticals LP $2,450.00 12/12/2024 Consulting Fee Undisputed 01/23/2026 1104488814 CMS
CALLIDITAS THERAPEUTICS US INC. $40.19 07/26/2024 Food and Beverage Undisputed 01/23/2026 1141519357 CMS
CALLIDITAS THERAPEUTICS US INC. $2,850.00 07/29/2024 Consulting Fee Undisputed 01/23/2026 1141519431 CMS
CALLIDITAS THERAPEUTICS US INC. $53.86 07/29/2024 Travel and Lodging Undisputed 01/23/2026 1141519433 CMS
CALLIDITAS THERAPEUTICS US INC. $111.16 10/23/2024 Food and Beverage Undisputed 01/23/2026 1141525338 CMS
Novo Nordisk Inc $16.94 09/17/2024 Food and Beverage Undisputed 01/23/2026 1096603169 CMS
Novo Nordisk Inc $14.85 09/30/2024 Food and Beverage Undisputed 01/23/2026 1096628851 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.